// App-Quantinova.ai

2645 : Mutations of STAT6 DNA Binding Domain Are Characteristic of PMBL and Belong to the Genetic Signature of This Entity.

Researchers

Presenter

  • Francois Lemonnier

Principal Investigators

  • Diane Damotte

  • Karen Leroy

  • Richard Delarue

  • Susana Ben-Neriah

  • Noel Milpied

  • Thierry Lamy

  • Herve Tilly

  • Randy D. Gascoyne

  • Christian Steidl

  • Philippe Gaulard

Medical Centers

  • CRLCC Henri Becquerel, Rouen, France

  • Dermatology, CHU, Rennes, France

  • U equipe, INSERM, CRETEIL, France

  • Service -anatomie et cytologie pathologiques, Hotel-Dieu, Paris, France

  • Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

  • Pathology, Universite Paris Est Creteil, AP-HP, Creteil Cedex, France

  • U955 equipe 13, INSERM, Creteil, France

  • CHU Bordeaux - Hopital Haut-leveque, Pessac, France,

  • Department of Medical Oncology, BC Cancer Agency Center for Lymphoid Cancer, Vancouver, BC, Canada

  • Nephrology, Necker Hospital, Paris, France

Locations

  • France

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Diffuse large B-cell lymphoma

  • Hodgkin's Lymphoma

  • Mediastinal mass

  • B cell lymphomas

  • Lymphomas

Biomarkers

  • Cluster of differentiation 8A

  • Programmed death-ligand 1

  • Human albumin

  • Lactate dehydrogenase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved